Data Monitoring: Meeting the Needs and Requirements of Sponsors and IRBs November 9, 2012

This webinar will cover NIH and FDA guidelines for data monitoring in clinical trials and show how you can implement an adequate data safety monitoring plan that reduces risks to those participating in a human subjects trial.

Why Should You Attend:

Both NIH and FDA had guidance that specifying the use of data and safety monitoring plans for clinical trials and those that involve human subjects. Knowledge of those requirements is needed by not only the investigators but by those reviewing the studies too.

This webinar will cover NIH and FDA guidelines for data monitoring in clinical trials and show how you can implement an adequate data safety monitoring plan that reduces risks to those participating in a human subjects trial. The presenter will discuss different types of data monitoring plans and committees and how the IRB interprets data monitoring as opposed to the industry.

Official Website: http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=702562?channel=yahooevent